JUNB and Miyoshi myopathy: While nuclear hormone receptor transcription factors (NHR-TFs) for which derivatives of natural ligands (e.g., dexamethasone, prednisolone) are well-established MM therapeutics, non-NHR-TFs including AP-1 have been considered “un-druggable” until most recently.